The human CYP4B1 protein was expressed in the liver of a transgenic mouse l
ine under the control of the promoter of the human apolipoprotein E (apo E)
gene. Hepatic microsomes of transgenic mice catalyzed omega -hydroxylation
of lauric acid and also activated 2-aminofluorene (2-AF), which is a typic
al substrate for CYP4B1, to mutagenic compounds detected by an umu gene exp
ression assay. These activities observed in transgenic mouse were efficient
ly inhibited by CYP4B1 antibody. However, such inhibition was not observed
in control mice. This is the first report to indicate catalytic activities
of human CYP4B1, For further characterization of human CYP4B1, a fusion pro
tein of CYP4B1 and NADPH-P450 reductase was expressed in yeast cells. It wa
s able to activate 2-AF and was also able to catalyze omega -hydroxylation
of lauric acid. This transgenic mouse line and the recombinant fusion prote
in provide a useful tool to study human CYP4B1 and its relation to chemical
toxicity and carcinogenesis. (C) 2001 Academic Press.